rhMG53-C14A

N/A

Report date: 2023/03/12 14:23:22

Base Information

Drug NamerhMG53-C14A
Drug Alias NamerhMG53-C14ArhMG-53-C-14-A
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionMitsugumin-53 replacements
TargetsMitsugumin-53
Therapy Area/IndicationsMyocardial Contusions
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesPeking University
China Registration ClassN/A

Develop Information

Active CompaniesPeking University
Inactive CompaniesN/A
Active IndicationsMyocardial Contusions
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A